Cases 51 - 60 of 71
Connecticut et al v. Teva Pharmaceuticals USA, Inc.
as 2:2019cv02407
Plaintiff:
State of North Dakota, State of North Carolina, State of Minnesota and others
Defendant:
ACTAVIS PHARMA, INC., Richard Rogerson, WOCKHARDT USA LLC and others
Cause Of Action: 15 U.S.C. § 1
Ridley v. Zhejiang Huahai Pharmaceutical Co., Ltd. et al
as 1:2019cv10070
Defendant:
Mylan Pharmaceuticals, Inc., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, DOES 1 THROUGH 100 and others
Plaintiff:
Margaret Ridley
In Re:
VALSARTAN N-NITROSODIMETHYLAMINE (NDMA) PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332
Hurens v. Aurobindo Pharma USA, Inc. et al
as 1:2019cv09165
In Re:
VALSARTAN N-NITROSODIMETHYLAMINE (NDMA) PRODUCTS LIABILITY LITIGATION
Defendant:
AUROBINDO PHARMA U.S.A., INC., AUROBINDO PHARMA LTD., AUROLIFE PHARMA LLC and others
Plaintiff:
Walter Hurens
Cause Of Action: 28 U.S.C. § 1332
Duffy et al v. Aurobindo Pharma USA, Inc. et al
as 1:2019cv08591
Defendant:
CVS HEALTH CO., Throggs Neck Pharmacy, RITE AID CORPORATION and others
Plaintiff:
Cecil Byrd, Elizabeth Duffy and Joseph Cacaccio
In Re:
VALSARTAN N-NITROSODIMETHYLAMINE (NDMA) PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332
Holland et al v. Zhejiang Huahai Pharmaceutical Co., Ltd. et al
as 1:2019cv07154
Defendant:
ACTAVIS PHARMA INC., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, AUROBINDO PHARMA U.S.A., INC. and others
Plaintiff:
JERRY HOLLAND and Kathryn Holland
In Re:
VALSARTAN N-NITROSODIMETHYLAMINE (NDMA) PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332
United HealthCare Services, Inc. v. Actavis Holdco U.S., Inc. et al
as 2:2019cv00629
Defendant:
MYLAN PHARMACEUTICALS INC, HI-TECH PHARMACAL CO., INC., PLIVA, INC. and others
Plaintiff:
UNITED HEALTHCARE SERVICES, INC.
Cause Of Action: 15 U.S.C. § 1
SCHICKER v. AUROBINDO PHARMA USA, INC.
as 3:2018cv12226
Defendant:
AUROBINDO PHARMA U.S.A., INC.
Plaintiff:
LYNNE SCHICKER
In Re:
FOSAMAX (ALENDRONATE SODIUM) PRODUCTS LIABILITY LITIGATION (NO. II)
Cause Of Action: 28 U.S.C. § 1441
Celgene Corporation v. Aurobindo Pharma Limited et al
as 1:2018cv01005
Plaintiff:
Celgene Corporation
Defendant:
Aurobindo Pharma U.S.A., Inc. and Aurobindo Pharma Limited
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. AUROBINDO PHARMA LIMITED et al
as 3:2018cv11219
Plaintiff:
CELGENE CORPORATION
Defendant:
AUROBINDO PHARMA U.S.A., INC. and AUROBINDO PHARMA LIMITED
Cause Of Action: 15 U.S.C. § 1126
Kissei Pharmaceutical Co., Ltd. et al v. Aurobindo Pharma Ltd. et al
as 1:2017cv01161
Plaintiff:
Kissei Pharmaceutical Co., Ltd. , Allegran Finance, LLC and Allergan Sales, LLC
Defendant:
Aurobindo Pharma Ltd. , Aurobindo Pharma U.S.A., Inc. and Aurobindo Pharma USA LLC
Counter_claimant:
Aurobindo Pharma U.S.A., Inc. , Aurobindo Pharma Ltd. and Aurobindo Pharma USA LLC
Counter_defendant:
Allegran Finance, LLC , Allergan Sales, LLC and Kissei Pharmaceutical Co., Ltd.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
